AFP and cancer: Both rAAV-AFP-pulsed and cancer cell lysate-pulsed DC induce DC maturation, though rAAV-AFP-engineered DC vaccine emerged as superior to cancer cell lysate-pulsed vaccine due to its higher potential for T cell induction [106].